Is Intraoperative Blood Cell Salvage Effective in Hip Surgery?^[*]

Abstract

Objective The present study aims to evaluate the efficacy of blood cell salvage (CS) as a method of reducing allogeneic blood transfusion in patients submitted to transtrochanteric femoral and hip surgeries due to injury.

Methods Prospective cohort of 38 patients from a school hospital submitted to hip or trochanteric surgeries and divided into two groups from August 2015 to February 2017. Patients with any malignancy or infectious condition were excluded from the study. Cell savage group (19 patients) received autologous blood using cell saver, whereas control group (19 patients) received just allogeneic blood, if needed. Red blood cell parameters, blood transfusion requirements, and clinical and surgical characteristics, such as age, gender, ASA scale and type of surgery, were compared both preoperatively and postoperatively. Data was processed in SPSS 20.0.

Results There were no differences in the clinical parameters studied (age, gender and ASA scale). Red blood cell parameters on the first day postoperative were higher in the cell savage group (p < 0.05). No significant reduction of intraoperative and postoperative allogeneic blood transfusion requirements was found.

Conclusion This study found that CS was not effective in reducing intraoperative and postoperative allogeneic blood transfusion requirements in patients submitted to transtrochanteric femoral and hip surgery.

Keywords

hip/surgery - femoral fractures - blood transfusion, autologous - blood transfusion

^* Work performed at Instituto Dr. José Frota, Fortaleza, CE, Brazil.

• Referências

• 1 Elawad AA, Öhlin AK, Berntorp E, Nilsson IM, Fredin H. Intraoperative autotransfusion in primary hip arthroplasty. A randomized comparison with homologous blood. Acta Orthop Scand 1991; 62 (06) 557-562
• 2 Bridgens JP, Evans CR, Dobson PM, Hamer AJ. Intraoperative red blood-cell salvage in revision hip surgery. A case-matched study. J Bone Joint Surg Am 2007; 89 (02) 270-275
• 3 McMurray MR, Birnbaum MA, Walter NE. Intraoperative autologous transfusion in primary and revision total hip arthroplasty. J Arthroplasty 1990; 5 (01) 61-65
• 4 Leigheb M, Pogliacomi F, Bosetti M, Boccafoschi F, Sabbatini M, Cannas M. , et al. Postoperative blood salvage versus allogeneic blood transfusion in total knee and hip arthroplasty: a literature review. Acta Biomed 2016; 87 (Suppl. 01) 6-14
• 5 Catling S, Joels L. Cell salvage in obstetrics: the time has come. BJOG 2005; 112 (02) 131-132
• 6 Kumar A. Perioperative management of anemia: limits of blood transfusion and alternatives to it. Cleve Clin J Med 2009; 76 (04) (Suppl. 04) S112-S118
• 7 Phillips SJ, Chavan R, Porter ML, Kay PR, Hodgkinson JP, Purbach B. , et al. Does salvage and tranexamic acid reduce the need for blood transfusion in revision hip surgery?. J Bone Joint Surg Br 2006; 88 (09) 1141-1142
• 8 Oliveira JAA, Façanha Filho FAM, Fernandes FV, Almeida PC, de Oliveira VF, Lima Verde SR. Is cell salvage cost-effective in posterior arthrodesis for adolescent idiopathic scoliosis in the public health system?. J Spine Surg 2017; 3 (01) 2-8
• 9 Lemaire R. Strategies for blood management in orthopaedic and trauma surgery. J Bone Joint Surg Br 2008; 90 (09) 1128-1136
• 10 Oliveira JAA, Façanha Filho FAM, Feijão SX, Fernandes FV, Almeida PC, Carlos LM. , et al. Influence of Intraoperative Blood Salvage on Surgery for Scoliosis. Coluna/Columna 2017; 16 (01) 33-37
• 11 Semkiw LB, Schurman DJ, Goodman SB, Woolson ST. Postoperative blood salvage using the Cell Saver after total joint arthroplasty. J Bone Joint Surg Am 1989; 71 (06) 823-827
• 12 Shulman G, Grecula MJ, Hadjipavlou AG. Intraoperative autotransfusion in hip arthroplasty. Clin Orthop Relat Res 2002; (396) 119-130
• 13 Herd JM, Joseph JJ, McGarvey M, Tsimbouri P, Bennett A, Meek RM. , et al. Intraoperative cell salvage in revision hip surgery. Ann Med Surg (Lond) 2014; 3 (01) 8-12
• 14 van Bodegom-Vos L, Voorn VM, So-Osman C, Vliet Vlieland TP, Dahan A, Koopman-van Gemert AW. , et al. Cell Salvage in Hip and Knee Arthroplasty: A Meta-Analysis of Randomized Controlled Trials. J Bone Joint Surg Am 2015; 97 (12) 1012-1021
• 15 Hawi N, Kendoff DO, Hessling U, Haasper C, Gehrke T, Citak M. Effectiveness of an autologous transfusion system following cemented and non-cemented revisions of total hip arthroplasty. Int Orthop 2014; 38 (08) 1603-1608
• 16 Buget MI, Dikici F, Edipoğlu IS, Yıldız E, Valiyev N, Kucukay S. Two-year experience with cell salvage in total hip arthroplasty. Braz J Anesthesiol 2016; 66 (03) 276-282
• 17 Garvin KL, Feschuk CA, Sekundiak TD, Lyden ER. Blood salvage and allogenic transfusion needs in revision hip arthroplasty. Clin Orthop Relat Res 2005; 441 (441) 205-209